United Therapeutics has announced that its long-term pivotal Phase III ADVANCE OUTCOMES study met its primary endpoint, with ...
California-based immunotherapy company 3T Biosciences has appointed Rebeca Villarreal-Barragan as head of clinical operations ...
ESTEVE CDMO, the global pure-play contract development and manufacturing organization (CDMO) specializing in high-quality ...
February 2026 saw robust M&A activity across the pharmaceutical and biotechnology sectors, marked by several high-value ...
Iranian biopharma CinnaGen has secured European marketing authorization for Zandoriah (teriparatide), a biosimilar to Forsteo ...
Chinese biotech Innovent Biologics (HKEX: 01801) has secured approval from China’s National Medical Products Administration ...
US pharma giant Pfizer has withdrawn its European application for a marketing authorization of Zumrad (sasanlimab) for the ...
Chinese biotech Antengene (SEHK: 6996) has secured reimbursement in South Korea for Xpovio (selinexor) in combination with ...
Canada-based clinical-stage biotech Zymeworks ) and Royalty Pharma today announced an agreement for $250 million in funding ...
Progressive pulmonary fibrosis (PPF) represents one of the most challenging phenotypes within the interstitial lung disease ...
Sweden's pharmaceutical exports increased by more than 1% to 154 billion Swedish kroner in 2025. These new trade statistics ...
Indian drugmaker Aurobindo Pharma plans to scale up production of Penicillin-G to more than 10,000 metric tonnes annually ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results